All News

Popular HIV-1 med successful, particularly in order adults

July 07, 2020

Gilead will present new data on virologic suppression in adults 65 years and older at AIDS 2020: Virtual this week.

FDA clears first-in-class HIV-1 treatment

July 06, 2020

Drug helps with heavily-treatment experienced (HTE) adults with multidrug-resistant HIV-1 infection.

U.S. government secures remdesivir supply for COVID-19 patients

June 30, 2020

Price of the drug to treat hospitalized patients revealed.

FDA okays novel breast, colorectal cancer treatments

June 30, 2020

Colorectal cancer drug is the first immunotherapy administered as a first-line treatment and without chemotherapy.

Top 3 drugs to watch in second half 2020

June 23, 2020

These are the top 3 drugs recently approved — or soon to be approved by FDA — to watch in 2020.

Pharma maker seeks fast approval of lymphoma treatment

June 23, 2020

Investigational treatment will target marginal zone lymphoma (MZL) and follicular lymphoma (FL).

FDA pulls hydroxychloroquine for COVID-19, warns about other drug interaction

June 16, 2020

The agency revoked its emergency use authorization (EUA) for the drug, while warning about a dangerous interaction with remdesivir.

New pediatric HIV med available

June 15, 2020

The unique formulation is a dispersible tablet for children.

Major Metformin recalls underway

June 08, 2020

Five pharma markers are recalling the diabetes medication due to the presence of a carcinogenic ingredient.

Remdesivir for COVID-19 in short supply

June 08, 2020

HHS says supply could run out by the end of this month.

x